AUTUMN HANCOCK: Open Payments
NPI 1508398181 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 25 payments from 15 companies in 2025. Trend: 2023 $209 · 2024 $1,149 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $115 |
| Merck Sharp & Dohme LLC | 4 | $86 |
| PFIZER INC. | 2 | $62 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| ABBVIE INC. | 2 | $28 |
| Eisai Inc. | 1 | $22 |
| GENZYME CORPORATION | 1 | $20 |
| Novocure Inc. | 1 | $19 |
| ARRAY BIOPHARMA INC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: KEYTRUDA, XTANDI, SCEMBLIX, KISQALI, IMFINZI, Lenvima, SARCLISA, Optune Gio.
Industry payments across FL — which companies pay providers there.
